Overview

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To determine whether armodafinil is more effective than placebo in reducing fatigue.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Armodafinil
Modafinil